BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35961969)

  • 1. Identification of a BRAF/PA28γ/MEK1 signaling axis and its role in epithelial-mesenchymal transition in oral submucous fibrosis.
    Xie C; Li Z; Hua Y; Sun S; Zhong L; Chen Q; Feng H; Ji N; Li T; Zhou X; Zeng X; Tang Z; Sun C; Li J; Chen Q
    Cell Death Dis; 2022 Aug; 13(8):701. PubMed ID: 35961969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
    Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
    BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the arecoline/YAP1/BMP4 pathway in promoting endothelial-mesenchymal transition in oral submucous fibrosis.
    Yao M; Li J; Yuan S; Zhu X; Hu Z; Li Q; Cao R; Wang W; Fang C
    J Oral Pathol Med; 2020 Apr; 49(4):305-310. PubMed ID: 31397922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
    Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
    Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.
    Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z
    Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Notch Suppresses Epithelial-mesenchymal Transition and Induces Angiogenesis in Oral Submucous Fibrosis by Regulating TGF-β1.
    Wang J; Yang L; Mei J; Li Z; Huang Y; Sun H; Zheng K; Kuang H; Luo W
    Biochem Genet; 2024 Apr; 62(2):1055-1069. PubMed ID: 37526864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis.
    Yanjia H; Xinchun J
    Clin Chim Acta; 2007 Aug; 383(1-2):51-6. PubMed ID: 17537414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets.
    Qin X; Ning Y; Zhou L; Zhu Y
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral submucous fibrosis stimulates invasion and epithelial-mesenchymal transition in oral squamous cell carcinoma by activating MMP-2 and IGF-IR.
    Chen PN; Lin CW; Yang SF; Chang YC
    J Cell Mol Med; 2021 Oct; 25(20):9814-9825. PubMed ID: 34528373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis.
    Zheng L; Jian X; Guo F; Li N; Jiang C; Yin P; Min AJ; Huang L
    Oncol Rep; 2015 Jun; 33(6):2753-60. PubMed ID: 25872484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF4 as a novel target involved in malignant transformation of oral submucous fibrosis into oral squamous cell carcinoma.
    Meng L; Jiang Y; You J; Zhao P; Liu W; Zhao N; Yu Z; Ma J
    Sci Rep; 2023 Feb; 13(1):2775. PubMed ID: 36797470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
    Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
    Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skewed Th17/Treg balance during progression and malignant transformation of oral submucous fibrosis.
    Liu S; Liu Z; Shan Z; Liu Y; Chen T; Fang L; Quan H
    Oral Dis; 2022 Nov; 28(8):2119-2130. PubMed ID: 33749974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
    Li J; Feng X; Sun C; Zeng X; Xie L; Xu H; Li T; Wang R; Xu X; Zhou X; Zhou M; Zhou Y; Dan H; Wang Z; Ji N; Deng P; Liao G; Geng N; Wang Y; Zhang D; Lin Y; Ye L; Liang X; Li L; Luo G; Jiang L; Wang Z; Chen Q
    EBioMedicine; 2015 Aug; 2(8):851-8. PubMed ID: 26425691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
    Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
    Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
    Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
    J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change and pathological significance of glycogen content in oral squamous cell carcinoma and oral submucous fibrosis.
    Nie H; Hu X; Xiong H; Zeng L; Chen W; Su T
    Tissue Cell; 2024 Apr; 87():102337. PubMed ID: 38430849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Increased Connective Tissue Growth Factor in the Pathogenesis of Oral Submucous Fibrosis and its Malignant Transformation-An Immunohistochemical Study.
    Shah AM; Jain K; Desai RS; Bansal S; Shirsat P; Prasad P; Bodhankar K
    Head Neck Pathol; 2021 Sep; 15(3):817-830. PubMed ID: 33544386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma.
    Hu X; Xiong H; Wang W; Huang L; Mao T; Yang L; Wang C; Huang D; Wu J; Xia K; Su T
    Arch Oral Biol; 2020 Apr; 112():104687. PubMed ID: 32114253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
    Zhou S; Zhu Y; Li Z; Zhu Y; He Z; Zhang C
    J Cell Mol Med; 2021 Feb; 25(4):2262-2273. PubMed ID: 33345447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.